Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study

Prasugrel is converted into prasugrel active metabolite (PAM; R-138727) through the cytochrome P450-mediated conversion of an intermediate metabolite (PIM; R-95913). It is unknown whether PIM exerts any biological function. The FABOLUS-FASTER trial (Facilitation Through Aggrastat or Cangrelor Bolus...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Arteriosclerosis, thrombosis, and vascular biology Ročník 45; číslo 5; s. 792
Hlavní autoři:	Minuz, Pietro, Giorgetti, Alejandro, Meneguzzi, Alessandra, Taus, Francesco, Ribeiro, Rui P, Baldessari, Filippo, Gargiulo, Giuseppe, Gragnano, Felice, Landi, Antonio, Castelli, Marco, Gottardo, Rossella, Bortolotti, Federica, Verlato, Giuseppe, Fava, Cristiano, Cattaneo, Marco, Tagliaro, Franco, Valgimigli, Marco
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.05.2025
Témata:	Administration, Oral Aged Binding Sites Blood Platelets - drug effects Blood Platelets - metabolism Cell Adhesion Molecules - blood Female Humans Male Microfilament Proteins - blood Middle Aged Molecular Docking Simulation Molecular Dynamics Simulation P-Selectin Phosphoproteins - blood Phosphorylation Piperazines Platelet Activation - drug effects Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - blood Platelet Aggregation Inhibitors - pharmacokinetics Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - blood Prasugrel Hydrochloride - metabolism Prasugrel Hydrochloride - pharmacokinetics Purinergic P2Y Receptor Antagonists - administration & dosage Purinergic P2Y Receptor Antagonists - blood Purinergic P2Y Receptor Antagonists - pharmacokinetics Receptors, Purinergic P2Y12 - blood Receptors, Purinergic P2Y12 - drug effects ST Elevation Myocardial Infarction - blood ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - drug therapy ST Elevation Myocardial Infarction - therapy Vasodilator-Stimulated Phosphoprotein pharmacokinetics drug interactions prasugrel hydrochloride myocardial infarction platelet aggregation
ISSN:	1524-4636, 1524-4636
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!